BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35907039)

  • 1. Clonal evolution in adult TCF3::HLF-positive acute lymphoblastic leukemia undergoing stem cell transplantation.
    Ahmed MZ; Venkatadasari I; Dyer S; Wall K; Huxley E; Lovell R; Kishore B; Dassanayake H; Francis S; Nikolousis E; Kanellopoulos A
    Ann Hematol; 2022 Nov; 101(11):2553-2554. PubMed ID: 35907039
    [No Abstract]   [Full Text] [Related]  

  • 2. Aurora A kinase as a target for therapy in
    Leonard J; Wolf JS; Degnin M; Eide CA; LaTocha D; Lenz K; Wilmot B; Mullighan CG; Loh M; Hunger SP; Druker BJ; Loriaux MM; Tyner JW; Chang BH
    Haematologica; 2021 Nov; 106(11):2990-2994. PubMed ID: 34233449
    [No Abstract]   [Full Text] [Related]  

  • 3. T-Cell-Replete Haploidentical Hematopoietic Stem Cell Transplantation for a Patient With Tcf3-Hlf-Positive Acute Lymphoblastic Leukemia Extramedullary Relapse After Unrelated Bone Marrow Transplantation.
    Takahashi N; Mochizuki K; Kobayashi S; Ohara Y; Kudo S; Saito Y; Ikeda K; Ohto H; Kikuta A; Sano H
    J Pediatr Hematol Oncol; 2023 Apr; 45(3):e419-e422. PubMed ID: 36162014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cryptic TCF3 fusions in childhood leukemia: Detection by RNA sequencing.
    Salim M; Heldt F; Thomay K; Lentes J; Behrens YL; Kaune B; Möricke A; Cario G; Schieck M; Hofmann W; Davenport C; Steinemann D; Schrappe M; Schlegelberger B; Göhring G
    Genes Chromosomes Cancer; 2022 Jan; 61(1):22-26. PubMed ID: 34460133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Leukemogenic TCF3-HLF Complex Rewires Enhancers Driving Cellular Identity and Self-Renewal Conferring EP300 Vulnerability.
    Huang Y; Mouttet B; Warnatz HJ; Risch T; Rietmann F; Frommelt F; Ngo QA; Dobay MP; Marovca B; Jenni S; Tsai YC; Matzk S; Amstislavskiy V; Schrappe M; Stanulla M; Gstaiger M; Bornhauser B; Yaspo ML; Bourquin JP
    Cancer Cell; 2019 Dec; 36(6):630-644.e9. PubMed ID: 31735627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical outcomes and genomic landscapes of acute lymphoblastic leukemia patients with E2A-PBX1: A 10-year retrospective study.
    Zhou B; Chu X; Tian H; Liu T; Liu H; Gao W; Chen S; Hu S; Wu D; Xu Y
    Am J Hematol; 2021 Nov; 96(11):1461-1471. PubMed ID: 34406703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomics and drug profiling of fatal TCF3-HLF-positive acute lymphoblastic leukemia identifies recurrent mutation patterns and therapeutic options.
    Fischer U; Forster M; Rinaldi A; Risch T; Sungalee S; Warnatz HJ; Bornhauser B; Gombert M; Kratsch C; Stütz AM; Sultan M; Tchinda J; Worth CL; Amstislavskiy V; Badarinarayan N; Baruchel A; Bartram T; Basso G; Canpolat C; Cario G; Cavé H; Dakaj D; Delorenzi M; Dobay MP; Eckert C; Ellinghaus E; Eugster S; Frismantas V; Ginzel S; Haas OA; Heidenreich O; Hemmrich-Stanisak G; Hezaveh K; Höll JI; Hornhardt S; Husemann P; Kachroo P; Kratz CP; Te Kronnie G; Marovca B; Niggli F; McHardy AC; Moorman AV; Panzer-Grümayer R; Petersen BS; Raeder B; Ralser M; Rosenstiel P; Schäfer D; Schrappe M; Schreiber S; Schütte M; Stade B; Thiele R; von der Weid N; Vora A; Zaliova M; Zhang L; Zichner T; Zimmermann M; Lehrach H; Borkhardt A; Bourquin JP; Franke A; Korbel JO; Stanulla M; Yaspo ML
    Nat Genet; 2015 Sep; 47(9):1020-1029. PubMed ID: 26214592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comprehensive chromosomal aberrations in a case of a patient with TCF3-HLF-positive BCP-ALL.
    Lejman M; Włodarczyk M; Zawitkowska J; Kowalczyk JR
    BMC Med Genomics; 2020 Apr; 13(1):58. PubMed ID: 32245383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel TCF3-HLF fusion transcript in acute lymphoblastic leukemia with a t(17;19)(q22;p13).
    Panagopoulos I; Micci F; Thorsen J; Haugom L; Tierens A; Ulvmoen A; Heim S
    Cancer Genet; 2012 Dec; 205(12):669-72. PubMed ID: 23181981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCF3 gene rearrangements in pediatric B-cell acute lymphoblastic leukemia-A single center experience.
    Zerkalenkova E; Menchits Y; Borkovskaia A; Sokolova S; Soldatkina O; Mikhailova E; Popov A; Komkov A; Rumiantseva Y; Karachunskii A; Olshanskaya Y
    Int J Lab Hematol; 2023 Aug; 45(4):533-540. PubMed ID: 37058324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterisation of genomic translocation breakpoints and identification of an alternative TCF3/PBX1 fusion transcript in t(1;19)(q23;p13)-positive acute lymphoblastic leukaemias.
    Paulsson K; Jonson T; Ora I; Olofsson T; Panagopoulos I; Johansson B
    Br J Haematol; 2007 Jul; 138(2):196-201. PubMed ID: 17593026
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Li MJ; Yu CH; Chou SW; Su YH; Liao KW; Chang HH; Yang YL
    JCO Precis Oncol; 2022 Aug; 6():e2200236. PubMed ID: 36001860
    [No Abstract]   [Full Text] [Related]  

  • 13. Myeloid lineage switch following chimeric antigen receptor T-cell therapy in a patient with TCF3-ZNF384 fusion-positive B-lymphoblastic leukemia.
    Oberley MJ; Gaynon PS; Bhojwani D; Pulsipher MA; Gardner RA; Hiemenz MC; Ji J; Han J; O'Gorman MRG; Wayne AS; Raca G
    Pediatr Blood Cancer; 2018 Sep; 65(9):e27265. PubMed ID: 29797659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dasatinib and allogeneic stem cell transplantation enable sustained response in an elderly patient with
    Frech M; Jehn LB; Stabla K; Mielke S; Steffen B; Einsele H; Metzelder SK; Neubauer A
    Haematologica; 2017 Apr; 102(4):e160-e162. PubMed ID: 28057740
    [No Abstract]   [Full Text] [Related]  

  • 15. Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.
    Spinelli O; Peruta B; Tosi M; Guerini V; Salvi A; Zanotti MC; Oldani E; Grassi A; Intermesoli T; Micò C; Rossi G; Fabris P; Lambertenghi-Deliliers G; Angelucci E; Barbui T; Bassan R; Rambaldi A
    Haematologica; 2007 May; 92(5):612-8. PubMed ID: 17488684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durable remissions in
    Mouttet B; Vinti L; Ancliff P; Bodmer N; Brethon B; Cario G; Chen-Santel C; Elitzur S; Hazar V; Kunz J; Möricke A; Stein J; Vora A; Yaman Y; Schrappe M; Anak S; Baruche A; Locatelli F; von Stackelberg A; Stanulla M; Bourquin JP
    Haematologica; 2019 Jun; 104(6):e244-e247. PubMed ID: 30765470
    [No Abstract]   [Full Text] [Related]  

  • 17. Characterization of TCF3 rearrangements in pediatric B-lymphoblastic leukemia/lymphoma by mate-pair sequencing (MPseq) identifies complex genomic rearrangements and a novel TCF3/TEF gene fusion.
    Rowsey RA; Smoley SA; Williamson CM; Vasmatzis G; Smadbeck JB; Ning Y; Greipp PT; Hoppman NL; Baughn LB; Ketterling RP; Peterson JF
    Blood Cancer J; 2019 Oct; 9(10):81. PubMed ID: 31575852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SNX2-ABL1-positive acute lymphoblastic leukemia possibly has a poor prognosis.
    Mu Q; Guo L; Hu Y; Sheng L; Zhang Y; Wu N; Chen Y; Shi C; Shi S; Wu Y; Ouyang G
    Leuk Lymphoma; 2017 Sep; 58(9):1-3. PubMed ID: 28278724
    [No Abstract]   [Full Text] [Related]  

  • 19.
    Tasian SK
    Haematologica; 2023 Jul; 108(7):1713-1714. PubMed ID: 37392046
    [No Abstract]   [Full Text] [Related]  

  • 20. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
    Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.